Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients

被引:3
作者
Crippa, Stefano [1 ]
Malleo, Giuseppe [2 ]
Langella, Serena [3 ]
Ricci, Claudio [4 ,5 ]
Casciani, Fabio [2 ]
Belfiori, Giulio [1 ]
Galati, Sara [3 ]
Ingaldi, Carlo [4 ,5 ]
Lionetto, Gabriella [2 ]
Ferrero, Alessandro [3 ]
Casadei, Riccardo [4 ,5 ]
Ercolani, Giorgio [5 ,6 ]
Salvia, Roberto [2 ]
Falconi, Massimo [1 ]
Cucchetti, Alessandro [5 ,6 ]
机构
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Pancreas Translat & Clin Res Ctr, Div Pancreat Surg, Milan, Italy
[2] Univ Verona Hosp Trust, Pancreas Inst, Dept Gen & Pancreat Surg, Policlin GB Rossi, Verona, Italy
[3] Mauriziano Hosp, Dept Gen & Oncol Surg, Turin, Italy
[4] Azienda Osped Univ Bologna, Div Pancreat Surg, Bologna, Italy
[5] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy
[6] Morgagni Pierantoni Hosp, Dept Surg, Forli, Italy
关键词
Pancreatic cancer; cure; cure probability; survival; surgery; neoadjuvant treatment; recurrence; HEPATIC RESECTION; CANCER; GEMCITABINE;
D O I
10.1097/SLA.0000000000006166
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective:To assess the probability of being cured of pancreatic ductal adenocarcinoma (PDAC) by pancreatic surgery.Background:Statistical cure implies that a patient treated for a specific disease will have the same life expectancy as if he/she never had that disease.Methods:Patients who underwent pancreatic resection for PDAC between 2010 and 2021 were retrospectively identified using a multi-institutional database. A nonmixture statistical cure model was applied to compare disease-free survival to the survival expected for a matched general population.Results:Among 2554 patients, either in the setting of upfront (n=1691) or neoadjuvant strategy (n=863), the cure model showed that the probability that surgery would offer the same life expectancy (and tumor-free) as the matched general population was 20.4% (95% CI: 18.3, 22.5). Cure likelihood reached the 95% of certainty (time to cure) after 5.3 years (95% CI: 4.7, 6.0). A preoperative model was developed based on tumor stage at diagnosis (P=0.001), radiologic size (P=0.001), response to chemotherapy (P=0.007), American Society of Anesthesiology class (P=0.001), and preoperative Ca19-9 (P=0.001). A postoperative model with the addition of surgery type (P=0.015), pathologic size (P=0.001), tumor grading (P=0.001), resection margin (P=0.001), positive lymph node ratio (P=0.001), and the receipt of adjuvant therapy (P=0.001) was also developed.Conclusions:Patients operated for PDAC can achieve a life expectancy similar to that of the general population, and the likelihood of cure increases with the passage of recurrence-free time. An online calculator was developed and available at https://aicep.website/?cff-form=15.
引用
收藏
页码:999 / 1005
页数:7
相关论文
共 20 条
[1]  
[Anonymous], Surgery for Pancreatic Cancer
[2]   Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy [J].
Balzano, Gianpaolo ;
Capretti, Giovanni ;
Callea, Giuditta ;
Cantu, Elena ;
Carle, Flavia ;
Pezzilli, Raffaele .
HPB, 2016, 18 (05) :470-478
[3]   Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival [J].
Belfiori, Giulio ;
Crippa, Stefano ;
Francesca, Aleotti ;
Pagnanelli, Michele ;
Tamburrino, Domenico ;
Gasparini, Giulia ;
Partelli, Stefano ;
Andreasi, Valentina ;
Rubini, Corrado ;
Zamboni, Giuseppe ;
Falconi, Massimo .
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (13) :8249-8260
[4]   Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis [J].
Blackford, Amanda L. ;
Canto, Marcia Irene ;
Klein, Alison P. ;
Hruban, Ralph H. ;
Goggins, Michael .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (11) :1162-1169
[5]   FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer [J].
Conroy, T. ;
Hammel, P. ;
Hebbar, M. ;
Ben Abdelghani, M. ;
Wei, A. C. ;
Raoul, J. -L. ;
Chone, L. ;
Francois, E. ;
Artru, P. ;
Biagi, J. J. ;
Lecomte, T. ;
Assenat, E. ;
Faroux, R. ;
Ychou, M. ;
Volet, J. ;
Sauvanet, A. ;
Breysacher, G. ;
Di Fiore, F. ;
Cripps, C. ;
Kavan, P. ;
Texereau, P. ;
Bouhier-Leporrier, K. ;
Khemissa-Akouz, F. ;
Legoux, J. -L. ;
Juzyna, B. ;
Gourgou, S. ;
O'Callaghan, C. J. ;
Jouffroy-Zeller, C. ;
Rat, P. ;
Malka, D. ;
Castan, F. ;
Bachet, J. -B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) :2395-2406
[6]   Cure Model Survival Analysis After Hepatic Resection for Colorectal Liver Metastases [J].
Cucchetti, Alessando ;
Ferrero, Alessandro ;
Cescon, Matteo ;
Donadon, Matteo ;
Russolillo, Nadia ;
Ercolani, Giorgio ;
Stacchini, Giacomo ;
Mazzotti, Federico ;
Torzilli, Guido ;
Pinna, Antonio Daniele .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (06) :1908-1914
[7]   The chances of hepatic resection curing hepatocellular carcinoma [J].
Cucchetti, Alessandro ;
Zhong, Jianhong ;
Berhane, Sarah ;
Toyoda, Hidenori ;
Shi, KeQing ;
Tada, Toshifumi ;
Chong, Charing C. N. ;
Xiang, Bang-De ;
Li, Le-Qun ;
Lai, Paul B. S. ;
Ercolani, Giorgio ;
Mazzaferro, Vincenzo ;
Kudo, Masatoshi ;
Cescon, Matteo ;
Pinna, Antonio Daniele ;
Kumada, Takashi ;
Johnson, Philip J. .
JOURNAL OF HEPATOLOGY, 2020, 72 (04) :711-717
[8]   Machine Learning Predictive Model to Guide Treatment Allocation for Recurrent Hepatocellular Carcinoma After Surgery [J].
Famularo, Simone ;
Donadon, Matteo ;
Cipriani, Federica ;
Fazio, Federico ;
Ardito, Francesco ;
Iaria, Maurizio ;
Perri, Pasquale ;
Conci, Simone ;
Dominioni, Tommaso ;
Lai, Quirino ;
La Barba, Giuliano ;
Patauner, Stefan ;
Molfino, Sarah ;
Germani, Paola ;
Zimmitti, Giuseppe ;
Pinotti, Enrico ;
Zanello, Matteo ;
Fumagalli, Luca ;
Ferrari, Cecilia ;
Romano, Maurizio ;
Delvecchio, Antonella ;
Valsecchi, Maria Grazia ;
Antonucci, Adelmo ;
Piscaglia, Fabio ;
Farinati, Fabio ;
Kawaguchi, Yoshikuni ;
Hasegawa, Kiyoshi ;
Memeo, Riccardo ;
Zanus, Giacomo ;
Griseri, Guido ;
Chiarelli, Marco ;
Jovine, Elio ;
Zago, Mauro ;
Abu Hilal, Moh'd ;
Tarchi, Paola ;
Baiocchi, Gian Luca ;
Frena, Antonio ;
Ercolani, Giorgio ;
Rossi, Massimo ;
Maestri, Marcello ;
Ruzzenente, Andrea ;
Grazi, Gian Luca ;
Dalla Valle, Raffaele ;
Romano, Fabrizio ;
Giuliante, Felice ;
Ferrero, Alessandro ;
Aldrighetti, Luca ;
Bernasconi, Davide P. ;
Torzilli, Guido .
JAMA SURGERY, 2023, 158 (02) :192-202
[9]   Hospital volume and outcomes of pancreatic cancer: a Finnish population-based nationwide study [J].
Huhta, Heikki ;
Nortunen, Minna ;
Merilainen, Sanna ;
Helminen, Olli ;
Kauppila, Joonas H. .
HPB, 2022, 24 (06) :841-847
[10]  
Istat, IstatData-Italian Statistics Database